American Century Companies’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
783,166
+3,400
| +0.4% | +$44.6K | 0.01% | 1363 |
|
|
2025
Q1 | $17.2M | Buy |
779,766
+9,413
| +1% | +$207K | 0.01% | 1114 |
|
|
2024
Q4 | $20.6M | Sell |
770,353
-164,034
| -18% | -$4.38M | 0.01% | 1027 |
|
|
2024
Q3 | $24.9M | Buy |
934,387
+74,320
| +9% | +$1.98M | 0.01% | 927 |
|
|
2024
Q2 | $15.5M | Buy |
860,067
+300,733
| +54% | +$5.42M | 0.01% | 1059 |
|
|
2024
Q1 | $10.2M | Sell |
559,334
-211,118
| -27% | -$3.85M | 0.01% | 1199 |
|
|
2023
Q4 | $8.43M | Buy |
770,452
+242,613
| +46% | +$2.65M | 0.01% | 1218 |
|
|
2023
Q3 | $3.02M | Buy |
527,839
+7,337
| +1% | +$42K | ﹤0.01% | 1532 |
|
|
2023
Q2 | $4.03M | Buy |
520,502
+11,440
| +2% | +$88.7K | ﹤0.01% | 1381 |
|
|
2023
Q1 | $3.39M | Buy |
509,062
+3,379
| +0.7% | +$22.5K | ﹤0.01% | 1406 |
|
|
2022
Q4 | $4.52M | Buy |
505,683
+6,822
| +1% | +$61K | ﹤0.01% | 1259 |
|
|
2022
Q3 | $4.91M | Buy |
498,861
+194,148
| +64% | +$1.91M | ﹤0.01% | 1117 |
|
|
2022
Q2 | $2.43M | Sell |
304,713
-168
| -0.1% | -$1.34K | ﹤0.01% | 1356 |
|
|
2022
Q1 | $2.96M | Buy |
304,881
+502
| +0.2% | +$4.87K | ﹤0.01% | 1284 |
|
|
2021
Q4 | $4.65M | Buy |
304,379
+9,967
| +3% | +$152K | ﹤0.01% | 1082 |
|
|
2021
Q3 | $4.89M | Buy |
294,412
+102
| +0% | +$1.69K | ﹤0.01% | 1029 |
|
|
2021
Q2 | $6.28M | Buy |
294,310
+15,733
| +6% | +$336K | ﹤0.01% | 938 |
|
|
2021
Q1 | $9.05M | Buy |
+278,577
| New | +$9.05M | 0.01% | 801 |
|